Hepatobiliary & Pancreatic Diseases International

期刊全称

期刊缩写

HEPATOB PANCREAT DIS

涉及主题

医学内科学生物外科遗传学化学生物化学胃肠病学病理放射科内分泌学免疫学癌症研究移植

期刊介绍

Hepatobiliary & Pancreatic Diseases International (HBPD INT) (ISSN 1499-3872 / CN 33-1391/R) a bimonthly journal published by First Affiliated Hospital, Zhejiang University School of Medicine, China. It publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases. Papers cover the medical, surgical, radiological, pathological, biochemical, physiological and historical aspects of the subject areas under the headings Liver, Biliary, Pancreas, Transplantation, Research, Special Reports, Editorials, Review Articles, Brief Communications, Clinical Summary, Clinical Images and Case Reports. It also deals with the basic sciences and experimental work. The journal is abstracted and indexed in SCI-E, IM/MEDLINE, EMBASE/EM, CA, Scopus, ScienceDirect, etc.

期刊ISSN

print: 1499-3872

历年影响因子

2024年	2023年	2022年	2021年	2020年	2019年	2018年	2017年
3.6	3.3	3.355	3.78	2.428	1.576	1.5	1.649

历年发表/被引量

年份	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
发表量	39	83	119	141	127	138	127	131	117	121	119	114	108	109
被引量	1045	2452	2540	2520	2414	2030	1447	1263	1072	949	882	643	409	213

h-Index

自引率

5.60%

涉及的研究领域

医学-胃肠肝病学

中科院2025年分区

大类	小类	TOP期刊	综述期刊
3区	4区胃肠肝病学	否	否

WOS期刊分区

JCR学科分类

JCR分区学科名称	收录数据库	JCR分区	分区排名
GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q1	28/147

JCI学科分类

JCI分区学科名称	收录数据库	JCI分区	分区排名
GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	43/147

期刊主页

http://www.hbpdint.com https://www.journals.elsevier.com/hepatobiliary-and-pancreatic-diseases-international

投稿网址

http://mc03.manuscriptcentral.com/hbpdint

出版商

Elsevier (Singapore) Pte Ltd

出版国家（地区）

PEOPLES R CHINA

出版语言

English

出版周期

Bimonthly

每年出版文章数

Gold OA文章占比

0.00%

原创研究文献占比
(排除综述)

64.29%

SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1499-3872%5BISSN%5D

平均审稿周期

平均3.0个月

平均录用比例

约50%

Hepatobiliary & Pancreatic Diseases International

JCR学科分类

JCI学科分类

期刊相关文献 (15)

AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway

AGK2 预处理通过调节 MFN2-PERK 轴和铁死亡信号通路预防硫代乙酰胺诱发的急性肝衰竭

TuBG1 promotes hepatocellular carcinoma via ATR/P53-apoptosis and cycling pathways

TuBG1 通过 ATR/P53 凋亡和循环通路促进肝细胞癌

ADAMTS12 promotes migration and epithelial-mesenchymal transition and predicts poor prognosis for pancreatic cancer

ADAMTS12 促进迁移和上皮-间质转化并预测胰腺癌预后不良

Verteporfin synergizes the efficacy of anti-PD-1 in cholangiocarcinoma

维替泊芬可增强抗 PD-1 药物对胆管癌的疗效

Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway

漆黄素通过调节GSK3β/AMPK/NLRP3炎症小体通路减轻肝脏缺血再灌注损伤

Ghrelin inhibits IKKβ/NF-κB activation and reduces pro-inflammatory cytokine production in pancreatic acinar AR42J cells treated with cerulein

生长素释放肽抑制 IKKβ/NF-κB 活化并减少用 cerulein 处理的胰腺腺泡 AR42J 细胞中的促炎细胞因子产生

Translationally controlled tumor protein exerts a proinflammatory role in acute rejection after liver transplantation

翻译控制的肿瘤蛋白在肝移植后急性排斥中发挥促炎作用

Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer

胰腺癌患者的催产素和催产素受体改变、生存率降低和化疗耐药性增强

miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes

miR-222 靶向 ACOX1，促进肝细胞中甘油三酯的积累

Sphingosine kinase 1 knockout alleviates hepatic ischemia/reperfusion injury by attenuating inflammation and oxidative stress in mice

鞘氨醇激酶 1 敲除可通过减轻小鼠的炎症和氧化应激来减轻肝缺血/再灌注损伤